21 Invest

21 Invest announces the sale of SIFI to Spanish pharmaceutical group FAES FARMA, concluding a ten-year value creation journey alongside the company’s founding families and management team.   Since our investment, SIFI became an international leader in ophthalmology, with 70% of its revenue now generated outside of Italy and total revenues reaching €100 million. 21 Invest supported over €70 million in strategic investments, guided a significant organizational transformation, and helped build a culture rooted in innovation, digitalization, and sustainability.   A key achievement of this journey was the development and market approval of AKANTIOR®, the world’s first treatment for Acanthamoeba keratitis—an orphan drug representing SIFI and 21 Invest's commitment in shared value creation.   At 21 Invest we are proud to have contributed to a story of long-term impact and international expansion, that will continue its path with Faes Farma. Andrea Mazzucato, Stefano De Rossi, Massimo Galli

We’re pleased to share that 21 Invest will be attending SuperReturn Berlin! We look forward to connecting with you, exchanging insights on emerging industry trends, and sharing the latest milestones from our journey. Giuseppe Prestia, Andrea Mazzucato, Fabrice Voituron, Nicolas Vagner, Alice Baldassari, Laure Lagarde

21 Invest France wins “SMID Investment Fund of the Year” at the 2025 Private Equity Magazine Awards!   We are proud to see 21 Invest France recognized for its strong performance and activity in 2024, with key milestones including 4 new investments, 15 build-ups, 4 exits and €M 520 raised including a new flagship fund.   The Private Equity Magazine Awards celebrate the most active and impactful players in the French private equity market.   Congratulations to the entire 21 Invest France team for their dedication and contribution — and a heartfelt thank you to our portfolio's management teams, partners and entrepreneurs, whose unwavering commitment to deliver value to all our stakeholders is recognized through this award.

We are pleased to announce the final closing of 21 Invest France’s 6th vintage fund at €M 261 — exceeding our initial target of €M 250 and bringing total capital raised to €M 520. This total includes our flagship fund, along with €M 220 raised through a continuation fund dedicated to ProductLife Group (PLG) and three co-investment vehicles. A sincere thank you to our investors for their continued trust and support in this 6th-generation fund — a great recognition of our 30+ years of experience in the lower mid-market space. Many thanks as well to Reach Capital | Private Assets Advisor, Willkie Farr & Gallagher LLP, and DLA Piper for their valuable support throughout the fundraising process. With a clear investment strategy focused on supporting high-quality midcap companies in the Tech/Software, Healthcare, Business Services, and Education sectors, the fund is fully aligned with our mission of creating sustainable value for all stakeholders through strategic transformation. Already, five promising investments have been made: Agorastore – B2B platform for digital auctions CONEX – Customs software solutions ProductLife Group – Regulatory compliance for Life Sciences Rocamed SAM – Medical devices for endo-urology Donora (Leetchi x iRaiser) – Software for charity and digital fundraising We look forward to continuing this journey with our portfolio companies, investors, and partners! François Barbier, Fabrice Voituron, Céline Launay, Laure Lagarde

We are happy to announce CONSYDERA: the new Group that brings together Aussafer Due s.r.l., Ramo srl, Laserjet, and HAILTEC GmbH under one brand, creating a stronger, more integrated group in high-tech metal processing. With almost 500 people and nearly €M 100 in revenue, the Group combines expertise and advanced technologies to offer even more to customers. A step forward in its growth and international presence. Giacomo Citossi Andrea Mazzucato, Stefano De Rossi, Luca Martinuzzi

We are proud to announce that 21 Invest is expanding its investment scope by investing alongside Edizione S.p.A. in 2100 Ventures. A strategic step toward the future of innovation. 

We are proud to announce the FMA Assurances' acquisition of Ouest Assurances Group, a leading insurance broker specializing in leisure boat insurance and corporate risk solutions. This strategic acquisition strengthens FMA Group’s ambition to become one of French independent leading multi-specialist brokers. Dorothee CHATAIN

We are excited to announce that 21 Invest will be attending the 11th edition of IPEM in Cannes!   This event represents a valuable opportunity to connect, share insights, and explore potential collaborations in the private equity sector.   Our team looks forward to meeting you, discussing the latest industry trends and sharing updates on our journey.   Come visit us at stand E108 — see you next week in Cannes! François Barbier, Fabrice Voituron, Stéphane Perriquet, Antoine Vigneron, Dorothee CHATAIN, Laure Lagarde

The holiday season is a time for reflection, celebration and connection. Let’s carry the spirit of kindness and collaboration into the new year. Thank you for being part of 21 Invest's journey. Warm wishes for a wonderful holiday season and a happy 2025!

We are proud to announce the Omega Pharma SRL's acquisition of Inpha Nutraceuticals Srl, Italian company active in the research, development, and commercialization of nutraceuticals with a strong scientific foundation.   This acquisition marks the beginning of the consolidation process of Omega Pharma as an Italian leader in the dietary supplements sector, which will subsequently aim to grow in the European market. The group aims to exceed €M 30 in revenue by 2025, with over 150 sales representatives operating nationwide.   Andrea Mazzucato Stefano De Rossi Massimo Galli Valentina Mattiussi